ALK4290 is a potent, orally active small molecule CCR3 antagonist with a Ki of 3.2 nM for human CCR3. It is a research tool for investigating diseases like neovascular age-related macular degeneration and Parkinsonism, with applications in both in vitro and in vivo experimental models.
Molekulargewicht:
512.04
CAS Nummer:
[1251528-23-0]
Formel:
C27H34ClN5O3
Target-Kategorie:
Others,CCR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten